IL22RA2 and Hepatic fibrosis: Hence, the administration of IL-22BP inhibitors, such as IL-18, prostaglandin E2 (PGE2), NLRP3 and NLRP6 inflammasomes [98,99,100], may be a promising therapy for liver fibrosis [51].